Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – OCGN
-
NEW PUBLIC SAFETY FACILITY BREAKS GROUND
-
Kadant Authorizes Share Repurchase
-
Robbins LLP Reminds Investors of AKRO of the Pending Lead Plaintiff Deadline in the Akero Therapeutics, Inc. Class Action
-
MKS Instruments Announces Closing of Private Offering of $1.4 Billion of 1.25% Convertible Senior Notes, Including Full Exercise of Option to Purchase $200 Million of Additional Notes
-
CytomX Therapeutics Announces New Employment Inducement Grants
-
Scorpius Holdings, Inc. Announces Closing of Public Offering
-
FinWise Bancorp Announces Strategic Lending Program with Plannery to Provide Debt Consolidation Loans to Healthcare Professionals
-
Lamar Advertising Company Announces Cash Dividend on Common Stock
-
OI European Group B.V. Announces Upsizing and Pricing of Senior Notes Offering
-
NL INDUSTRIES, INC. ANNOUNCES QUARTERLY DIVIDEND AND RESULTS OF ANNUAL SHAREHOLDER MEETING
-
Voting Rights and Shares Capital of the Company
-
Burlington Stores, Inc. Announces First Quarter Fiscal Year 2024 Earnings Release Date, Conference Call and Webcast
-
Kadant Declares Cash Dividend
-
African Business Leaders Pledge to tackle Gender Inequality at the Africa CEO Forum
-
Fortrea Appoints Machelle Sanders to Board of Directors
-
NextNav Announces Appointment of Jonathan Marcus to Board of Directors
-
Merit Medical Shareholders Elect Silvia M. Perez as New Director
-
ArriVent Appoints John Hohneker, M.D., to its Board of Directors
-
Amwell CEO Roy Schoenberg to Speak at Stanford Disability & Telehealth Conference
-
New Study Published in JCO Precision Oncology Shows Myriad Genetics' Prolaris Test Can Predict Benefit of Hormone Therapy Treatment in Men with Localized Prostate Cancer
-
Spero Therapeutics to Participate in H.C. Wainwright Annual BioConnect Investor Conference
-
PowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders
-
Rapid7 to Attend Upcoming Investor Conferences
-
Epsilon Announces 2024 AGM Results
-
Ventyx Biosciences to Participate in Three Upcoming Investor Conferences
-
Amwell CEO Roy Schoenberg to Speak at Stanford Disability & Telehealth Conference
-
ZimVie to Participate in Upcoming Investor Conferences
-
TEN Ltd. Announces Delivery of Six Environmentally Friendly Vessels Since the Beginning of 2024
-
Option Care Health to Participate in Upcoming Investor Conferences
-
Earlyworks Announces Completion of ADS Ratio Change
-
Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference
-
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
-
New Study Published in JCO Precision Oncology Shows Myriad Genetics' Prolaris Test Can Predict Benefit of Hormone Therapy Treatment in Men with Localized Prostate Cancer
-
Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provide Business Update on Thursday, May 30, 2024
-
Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care Insights in Women at 2024 Digestive Disease Week (DDW) Conference
-
Applied Materials Announces Second Quarter 2024 Results
-
Unity Bancorp Declares Cash Dividend
-
Rent the Runway to Report First Quarter 2024 Results on June 6, 2024
-
NuCana Reports First Quarter 2024 Financial Results and Provides Business Update
-
FormFactor Announces Participation at Upcoming Conferences
-
Galapagos creates new subscription right plans
-
Erpminer, a digital currency mining machine company, has announced its entry into the Kenyan market to develop its online presence and support the country's economic transformation and growth.
-
Interim Management Statement Q1 2024 of Molecular Partners: Pipeline Progressing with Two Additional Programs to Enter the Clinic in 2025, Update to MP0533 Program
-
Texas Capital Bancshares, Inc. Appoints Mark Midkiff to Board of Directors
-
Inventiva announces the positive recommendation of the fourth DMC of the NATiV3 Phase III clinical trial with lanifibranor in patients with MASH/NASH
-
Robbins LLP Reminds Investors of EXAI of the Pending Lead Plaintiff Deadline in the Exscientia plc Class Action
-
DOCS INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Doximity, Inc. Investors with Substantial Losses Have Opportunity to Lead Case
-
TRC Companies Announces $1.5B in Funding for Clients’ Sustainable Transportation Projects, Including Zero Emission Trucking, Critical Charging Stations and Low Carbon Fueling Infrastructure
-
Steel Reef Announces Election of Board of Directors

